Loading...

Same-Day & First-Morning PBMC Processing Services

High-Volume Whole Blood & Leukopak Processing | Nationwide Overnight Acceptance

Peripheral Blood Mononuclear Cell (PBMC) integrity is time-sensitive. From the moment of venipuncture, cellular stress responses begin altering gene expression, viability, cytokine background, and functional immune signaling.

At Accelevir, we have engineered a high-precision PBMC processing platform designed to minimize draw-to-processing time — while accommodating high blood volumes and leukapheresis collections that many large laboratories decline.

We do not impose restrictive volume limits.
We do not avoid complex leukopak processing.
We do not delay sample initiation.

We process immediately.

Why PBMC Processing Time Matters

PBMCs are highly dynamic immune cells. Delays in processing can result in:

  • Reduced cell viability
  • Increased apoptosis
  • Altered transcriptomic signatures
  • Cytokine drift and immune activation artifacts
  • Compromised T-cell functional assays
  • Variability in downstream flow cytometry and molecular assays

Studies have demonstrated that extended pre-processing delays (>8–24 hours) significantly alter immunophenotypic distribution and functional responsiveness.

For sponsors conducting:

  • Immuno-oncology trials
  • Autoimmune disease studies
  • Vaccine trials
  • Cell and gene therapy development
  • Infectious disease research
  • Translational immunology programs

Processing time is not logistics — it is data integrity.

Our Operational Model

Nationwide Overnight → Immediate Morning Processing

We accept:

  • Fresh whole blood (EDTA, Heparin, CPT-compatible formats)
  • Large-volume whole blood collections
  • Leukopak / leukapheresis collections
  • Custom anticoagulant configurations (validated upon request)

Samples shipped overnight are:

  •  Received at opening
  • Logged immediately into LIMS
  • Initiated for density gradient separation within hours of arrival
  • Processed under validated SOPs
  • Subjected to viability and yield QC
  • Cryopreserved under controlled-rate freezing when required

Our laboratory workflow ensures minimal delay between receipt and PBMC isolation.

High-Volume Whole Blood Processing (No Arbitrary Caps)

Many large reference laboratories impose volume limits or discourage processing of:

  • 60–100 mL whole blood
  • Multi-tube clinical collections
  • High-density clinical trial shipments

Accelevir specializes in:

  • Large-volume PBMC isolation
  • Scaled centrifugation workflows
  • Multi-batch density separation
  • Custom Ficoll or Lymphoprep workflows
  • Controlled aggregation and pooling strategies

We support clinical protocols requiring:

  • High-yield PBMC recovery
  • Longitudinal immune monitoring
  • Cell banking initiatives
  • Downstream NGS, qPCR, and functional immunology assays

Volume is not a barrier — it is a variable we engineer around.

Leukopak & Leukapheresis Processing Expertise

Leukopak samples require:

  • Specialized handling
  • High-capacity centrifugation
  • Experienced technical staff
  • Accurate cell counting and viability assessment
  • Sterile processing conditions

Many commercial labs avoid leukopak processing due to operational burden.

Accelevir has built workflows specifically to support:

  • Research-use leukopaks
  • Clinical leukapheresis collections
  • CAR-T development programs
  • Cell therapy manufacturing support
  • Immune profiling of high-yield collections

We can process, cryopreserve, phenotype, QC, and prepare PBMC fractions suitable for:

  • T-cell engineering
  • NK-cell expansion
  • Functional ELISpot
  • Flow cytometry panels
  • Bulk RNA-Seq
  • Single-cell sequencing
  • DNA methylation studies
  • Telomere analysis
  • Viral reservoir quantification

Quality Control & Documentation

Each PBMC processing run includes:

  • Total nucleated cell counts
  • Viability assessment (Trypan Blue or automated fluorescence-based)
  • Yield calculations
  • Cryopreservation documentation
  • SOP traceability
  • Chain-of-custody tracking

Optional add-ons:

  • PBMC QC phenotyping panel
  • CD3/CD4/CD8 baseline immunophenotyping
  • Mycoplasma screening
  • Endotoxin screening
  • Functional stimulation assays
  • Viability recovery testing post-thaw

Our experience over 10+ years working with PBMCs has shown that improper processing leads to lost trials, unusable data, and significant sponsor cost exposure.

We built this platform to prevent that outcome.

Who We Support

Accelevir provides PBMC processing services for:

  • Biotechnology companies
  • Academic medical centers
  • CRO partners
  • Cell & gene therapy developers
  • Immunology-focused sponsors
  • Clinical trial sites
  • Translational research groups

We are particularly well suited for studies involving:

  • Oncology
  • Autoimmune disease
  • Dermatology immunology
  • Rheumatology
  • Infectious disease
  • HIV reservoir studies
  • Vaccine development

Why Sponsors Choose Accelevir

Unlike high-volume commercial laboratories:

  • We accept high blood volumes
  • We process leukopaks without hesitation
  • We initiate processing immediately upon receipt
  • We operate with scientific leadership oversight
  • We provide consultative support on pre-analytical variables
  • We understand how PBMC biology impacts downstream assays

Our team includes PhD-level immunology expertise with extensive experience in translational immune cell handling.

We are not a specimen warehouse.
We are an immunology processing platform.

Geographic Strategy & Regional Advantage

Located in Baltimore, Maryland, we are positioned to support:

  • Mid-Atlantic clinical sites
  • Washington DC corridor
  • Northern Virginia biotech region
  • Northeast same-day delivery pathways
  • Nationwide overnight programs

As we expand our rapid processing network, we are building one of the most responsive PBMC infrastructures in the region.

Frequently Asked Questions

Do you accept large-volume whole blood?

Yes. We routinely process high-volume collections and multi-tube shipments.

Do you process leukopaks?

Yes. We specialize in leukopak handling and high-yield PBMC isolation.

What is your maximum volume?

We evaluate each protocol individually and scale centrifugation capacity accordingly.

Do you provide same-day processing?

For regional programs — yes. For nationwide sponsors, we process immediately upon overnight receipt.

Can you integrate QC and immunophenotyping?

Yes. We offer integrated PBMC QC panels and advanced immunological testing.

Request a PBMC Processing Consultation

If you are designing a study where immune cell integrity matters, contact Accelevir to discuss:

  • Sample logistics planning
  • Volume feasibility
  • Processing window optimization
  • Cryopreservation strategy
  • Integrated downstream testing


We are happy to review your protocol and design a processing plan that protects your data from pre-analytical degradation.

Independent Characterization of PBMC Phenotype, Function, and Quality

Ensure your study starts with high-quality, functionally validated PBMCs. Accelevir provides expert PBMC isolation, cryopreservation, and comprehensive quality control — including viability, recovery, immunophenotyping, and functional assessment. We also cross-validate sponsor-prepared PBMCs to ensure consistency across labs and clinical sites. Reliable cells. Reproducible data. Reduced risk. Complete the form below to request a quote and initiate your PBMC processing.

Sponsor & Project Information

Provide your organization and study details.

Name(Required)

Sample Overview: Cryopreserved PBMCs | Quantity: 3 vials | Cell Count: 5 million cells per vial

Cryopreserved PBMCs Quantity: 3 vials Cell Count: 5 million cells per vial. All samples must be fully de-identified prior to shipment. A detailed sample manifest must be included with each shipment. Upon completion of the study, all remaining samples will be discarded and destroyed by Accelevir in accordance with institutional biosafety and compliance policies.

Sample Source(Required)
Estimated Number of Donors(Required)

Collection & Processing Conditions

Specify how samples are collected and processed.

PBMC Isolation Methods

Please provide as much detail as possible
(Non-MDC) PBMC Isolation Method
Please provide as much detail as possible
Cryopreservation Medium Used(Required)
Freezing Method(Required)
Current Storage

Scope & Acceptance Criteria

Define the scope of PBMC QC and immune phenotyping.

Primary purpose of PBMC QC and immune phenotyping(Required)
Specific acceptance criteria or viability thresholds required?(Required)
Require Certificate of Analysis (CoA) for PBMC QC release?(Required)

Timelines & Logistics

Provide information about sample readiness and logistics.

When will samples be ready to ship?(Required)
Will samples be submitted as(Required)

Standard Turnaround Time: 10-14 Business Days from Sample Receipt

Deliverables & Reporting: QC Summary Report (PDF) which includes post-thaw viability and recovery data, cell count reconciliation, phenotypic characterization, assay acceptance criteria, deviation notes (if any), and final QC disposition.

Would you like a sponsor review call with our scientific team to walk through results?(Required)

Biosafety & Chain of Custody (BSL-2 and under only)

Specify biosafety risks and documentation requirements.

Biosafety Risk(Required)
Accelevir is a BSL-2 Facility

Supporting Documents

Upload any supporting files for your request.

Max. file size: 2 GB.

Final Confirmation

Please confirm the accuracy of your information.

I confirm the above information is accurate to the best of my knowledge.(Required)

Accelevir | © 2023